Infection Probability Score: A predictor of Clostridium difficile-associated disease onset in patients with haematological malignancy

被引:17
作者
Apostolopoulou, Eleni [2 ]
Raftopoulos, Vasilios [1 ]
Terzis, Konstantinos [3 ]
Elefsiniotis, Ioannis [2 ]
机构
[1] Cyprus Univ Technol, Dept Nursing, Mediterranean Res Ctr Publ Hlth & Qual Care, Nicosia, Cyprus
[2] Univ Athens, Dept Nursing, Athens, Greece
[3] Halkida Gen Hosp, Halkida, Greece
关键词
Infection probability score; Healthcare-associated infections; APACHE II; KARNOFSKY; Hematology; Clostridium difficile-associated disease; RISK-FACTORS; NOSOCOMIAL INFECTIONS; HOSPITALIZED-PATIENTS; APACHE-II; DIARRHEA; TOXIN; EPIDEMIOLOGY; CHEMOTHERAPY; COLITIS; SURVEILLANCE;
D O I
10.1016/j.ejon.2010.11.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: to assess the predictive power of three systems: Infection Probability Score, APACHE II and KARNOFSKY score for the onset of Clostridium difficile-associated disease (CDAD) in hematology-oncology patients. Methods and sample: A retrospective pilot surveillance survey was conducted in the hematology unit of a general hospital in Greece. Data were collected by using an anonymous standardised case-record form. The sample consisted of 102 hospitalized patients. Results: The majority of the patients (33.3%) suffered from acute myeloid leukemia. The cumulative incidence of CDAD was 10.8% and the incidence rate of C difficile associated diarrhea was 5 per 1000 patient-days (14.2 per 1000 patient-days at risk). Patients with CDAD had twofold higher time of mean length of hospital stay compared with patients without CDAD (38.82 +/- 23.88 vs 19.45 +/- 14.56 days). Additionally patients with CDAD had received a greater number of different antibiotics compared to those without CDAD (5.18 +/- 1.99 vs 2.54 +/- 2.13), suffered from diabetes, from non Hodgkin's lymphoma, had a statistically significant higher duration of neutropenia >= 3 days and had received antifungal treatment. The best cutoff value of IPS for the prediction of CDAD was 13 with a sensitivity of 45.5% and a specificity of 82.4%. Conclusions: IPS is an early diagnostic test for CDAD detection. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:404 / 409
页数:6
相关论文
共 50 条
[41]   Past, present, and future therapies for Clostridium difficile-associated disease [J].
Surowiec, Dorothy ;
Kuyumjian, Arpi G. ;
Wynd, Michael A. ;
Cicogna, Cristina E. .
ANNALS OF PHARMACOTHERAPY, 2006, 40 (12) :2155-2163
[42]   The changing spectrum of Clostridium difficile-associated disease -: Implications for dentistry [J].
Blossom, David B. ;
Lewis, Felicia M. T. ;
McDonald, Clifford .
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2008, 139 (01) :42-47
[43]   Epidemiology of Clostridium difficile-associated disease in internal medicine wards in northern Italy [J].
Mellace, Luca ;
Consonni, Dario ;
Jacchetti, Gaia ;
Del Medico, Marta ;
Colombo, Riccardo ;
Velati, Marta ;
Formica, Simone ;
Cappellini, Maria Domenica ;
Castaldi, Silvana ;
Fabio, Giovanna .
INTERNAL AND EMERGENCY MEDICINE, 2013, 8 (08) :717-723
[44]   Clostridium difficile infection in patients with inflammatory bowel disease: a case control study [J].
Vitikainen, Krista ;
Haapamaki, Johanna ;
Farkkila, Martti ;
Anttila, Veli-Jukka ;
Arkkila, Perttu .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (08) :947-951
[45]   Mortality and risk stratification in patients with Clostridium difficile-associated diarrhoea [J].
Bhangu, S. ;
Bhangu, A. ;
Nightingale, P. ;
Michael, A. .
COLORECTAL DISEASE, 2010, 12 (03) :241-246
[46]   Clostridium difficile infection in patients with chronic kidney disease in Mexico [J].
Morfin-Otero, Rayo ;
Garza-Gonzalez, Elvira ;
Garcia Garcia, Guillermo ;
Perez-Gomez, Hector R. ;
Aguirre-Diaz, Sara A. ;
Gonzalez-Diaz, Esteban ;
Esparza-Ahumada, Sergio ;
Fernandez-Ramirez, Alfonso ;
Cardenas-Lara, Francisco ;
Martinez-Melendez, Adrian ;
Escobedo-Sanchez, Rodrigo ;
Ibarra-Hernandez, Margarita ;
Leon Garnica, Gerardo ;
Rodriguez-Noriega, Eduardo .
CLINICAL NEPHROLOGY, 2018, 90 (05) :350-356
[47]   Clostridium difficile-associated diarrhea:: Predictors of severity in patients presenting to the emergency department [J].
Andrews, CN ;
Raboud, J ;
Kassen, BO ;
Enns, R .
CANADIAN JOURNAL OF GASTROENTEROLOGY, 2003, 17 (06) :369-373
[48]   Clostridium difficile-associated disease: A primary clinical evaluation of elderly patients in a geriatric hospital [J].
Leibovitz, Arthur ;
Yarovoy, Alexandra ;
Sharshar, Nataly ;
Buckman, Zvi ;
Mizrahi, Eliyahy Haim ;
Lubart, Emily .
AMERICAN JOURNAL OF INFECTION CONTROL, 2016, 44 (10) :1158-1160
[49]   Resolution of Clostridium difficile-Associated Diarrhea in Patients With Cancer Treated With Fidaxomicin or Vancomycin [J].
Cornely, Oliver A. ;
Miller, Mark A. ;
Fantin, Bruno ;
Mullane, Kathleen ;
Kean, Yin ;
Gorbach, Sherwood .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (19) :2493-+
[50]   Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: a prospective and multicentre cohort study [J].
Len, Oscar ;
Rodriguez-Pardo, Dolores ;
Gavalda, Joan ;
Maria Aguado, Jose ;
Blanes, Marino ;
Borrell, Nuria ;
Bou, German ;
Carratala, Jordi ;
Miguel Cisneros, Jose ;
Fortun, Jesus ;
Gurgui, Merce ;
Montejo, Miguel ;
Cervera, Carlos ;
Munoz, Patricia ;
Asensio, Angel ;
Torre-Cisneros, Julian ;
Pahissa, Albert .
TRANSPLANT INTERNATIONAL, 2012, 25 (12) :1275-1281